On April 22, Rongtai health (603579) recently released its 2021 annual report. During the reporting period, the company achieved an operating revenue of 2612570399.83 yuan, a year-on-year increase of 29.3%; The net profit attributable to the shareholders of the listed company was 236336014.92 yuan, a year-on-year increase of 22.45%.

The net cash flow from operating activities during the reporting period was 337916376.3 yuan, and the net assets attributable to shareholders of the listed company by the end of 2021 were 1776370370.24 yuan.

During covid-19, the company achieved consolidated operating income of 2612570399.83 yuan, an increase of 29.30% over the same period last year. It was mainly due to the impact of the new crown pneumonia epidemic in the same period last year, which has resulted in a lower base of revenue last year.

According to the announcement, the total remuneration of directors, supervisors and senior managers during the reporting period was 7.376 million yuan. Chairman Lin Guangrong received a total pre tax remuneration of 772400 yuan from the company, director and general manager Lin Qi received a total pre tax remuneration of 1046400 yuan from the company, financial director Liao Jinhua received a total pre tax remuneration of 412400 yuan from the company, and director and Board Secretary Zhang Bo received a total pre tax remuneration of 826400 yuan from the company.

According to the announcement, the profit distribution plan or the plan for converting accumulation fund into share capital adopted by the board of directors during the reporting period, the company plans to distribute cash dividends of RMB 7.00 (including tax) to all shareholders with undistributed profits for every 10 shares based on the total share capital on the equity registration date (deducting the number of shares in the special account for share repurchase) when the profit distribution plan is implemented, and does not convert capital reserve into share capital. The remaining undistributed profits are carried forward to the following years.

According to the data of goubei.com, Rongtai health’s main business is the design, R & D, production and sales of massage appliances, as well as creating a massage experience platform and providing shared massage services.